Good start to the year for Gerresheimer

Düsseldorf (ots) -

- Querverweis: Ein Dokument liegt in der digitalen
Pressemappe zum Download vor und ist unter
http://www.presseportal.de/dokumente abrufbar -

- Group sales in the first quarter up 1.4% on like-for-like basis

- Profit from operations grew by 34% to EUR 12.3m

- Reiteration of guidance for the financial year 2010

Gerresheimer AG has got off to a good start in the new
financial year. In the first quarter (December 2009 to February
2010), sales increased by 1.4% on a like-for-like basis and
amounted to EUR 224.8m. Profit from operations even increased by
34%. "We have got off to a good start in the new financial year and
set the stage for further growth in 2010," said Dr. Axel Herberg,
CEO of Gerresheimer AG.

The leading supplier to the pharma and healthcare
industries achieved sales of EUR 224.8m matching the level of
sales in the strong first quarter of the previous year. Adjusted
for currency translation and the divested segment Technical Plastic
Systems sales improved by 1.4%. The first quarter was
characterized by a good business development in the pharma
segment, which accounts for around three quarters of total group
revenues, and slow spending in the cyclical segments.

The operating result (Adjusted EBITDA) of EUR 38.3m remained on
the level of the prior year. However the operating margin
(Adjusted EBITDA margin) increased to 17.0% (prior year: 16.1 %).

In the period under review profit from operations increased to
EUR 12.3m (Q1 2009: EUR 9.2m) and a positive net income of EUR 2.4m
(Q1 2009: EUR -1.1m) was achieved. This substantial profit
improvement is amongst other things due to an improved financial
result. Net financial debt declined compared to previous year's
quarter by approximately EUR 60m to EUR 402.6m.

Outlook

Gerresheimer AG remains on its path for growth. While the
company expects sales growth in the Pharma segment, the sustainable
recovery of the more cyclical segments Cosmetics and Life Science
Research is not yet visible.

The forecast for the 2010 financial year remains unchanged.
The company expects a sales increase of 2 to 4 percent and an
improved operating margin (Adjusted EBITDA Margin) of around 19.5
percent.

Thanks to a solid financing structure and strong operating cash
flow the company is well equipped to make future investments
in sustainable growth. Capital expenditure for the financial year
2010 will total around EUR 75m to 80m.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of
high- quality specialty products made of glass and plastic for the
global pharma & healthcare industry. Our wide product spectrum
ranges from pharmaceutical vials to complex drug delivery
systems, such as syringe systems, insulin pens and inhalers, for
safe dosage and application. Together with our partners we develop
solutions which set standards and have role-model status throughout
their respective business sectors.

Our Group of companies achieves in Europe, North and South
America and Asia sales of about E1 billion and employs around 9,400
people. Through top-class technologies, convincing innovations and
targeted investments we are systematically expanding our strong
market position.

Group Key Figures (IFRS; Financial Year end November 30)

|in EUR million |Q1 2010 |Q1 2009 |( % |FY 2009 |
|Revenues |224.8 |237.3 |-5.3 |1,000.2 |
|Group revenues excluding |224.8 |226.4 |-0.7 |970.8 |
|Technical Plastics1 | | | | |
|Adjusted EBITDA2 |38.3 |38.3 |+0.0 |185.9 |
|in % of revenues |17.0 |16.1 | |18.6 |
|Adjusted EBITDA2 |38.3 |39.0 |-1.8 |186.2 |
|excluding Technical | | | | |
|Plastics |17.0 |17.2 | |19.2 |
|in % of revenues | | | | |
|Profit from operations |12.3 |9.2 |+33.7 |60.5 |
|(EBIT) | | | | |
|Net income |2.4 |-1.1 |>100 |7.0 |
|Adjusted net income3 |7.3 |6.4 |+14.1 |45.2 |
|Earnings per share in E |0.06 |-0.05 |>100 |0.18 |
|Adjusted earnings per |0.22 |0.18 |+22.2 |1.34 |
|share4 in E | | | | |
|Equity ratio in % |35.9 |33.1 | |35.8 |
|Net Financial Debt |402.6 |460.3 |-12.5 |373.3 |
|Capital expenditure |15.9 |10.8 |+47.2 |86.4 |

1 The Technical Plastic Systems segment was sold with effect
from July 1, 2009.

2 Adjusted EBITDA: Earnings before income taxes, financial
result, amortization of fair value adjustments, extraordinary
depreciation, depreciation and amortization, restructuring
expenses and one-off income and expenses.

3 Adjusted net income: Consolidated profit before non-cash
amortization of fair value adjustments, special effects from
restructuring expenses, extraordinary depreciation, the balance
of one-off income and expenses (including significant non-cash
expenses) and the related tax effects.

4 Adjusted net income after minorities divided by 31.4m shares.

Originaltext: Gerresheimer AG
digital press kits: http://www.presseportal.de/pm/9072
press kits via RSS: http://www.presseportal.de/rss/pm_9072.rss2
ISIN: DE000A0LD6E6

Press Contact :

Investor Relations Contact
Anke Linnartz
Director Investor Relations
Phone +49 211 6181-314
Fax +49 211 6181-121
E-mail a.linnartz@gerresheimer.com

Burkhard Lingenberg
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-mail b.lingenberg@gerresheimer.com